![Akiko Futamura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Akiko Futamura is currently the President & Chief Executive Officer at Hinge Therapeutics, Inc. Prior to this, she was the President & Director at CarnaBio USA, Inc.
| Sociétés | Poste | Début |
|---|---|---|
Hinge Therapeutics, Inc.
 Hinge Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops novel drugs through artificial intelligence | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | President | 01/02/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
CarnaBio USA, Inc.
CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | Distribution Services |
Hinge Therapeutics, Inc.
Hinge Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops novel drugs through artificial intelligence | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
